Records outcomes of tenecteplase use in people with acute ischemic stroke
Studies patients with sudden stroke from a blood clot who received tenecteplase.
Plain-language title generated from the registry record
Registry title: Tenecteplase Treatment in Ischemic Stroke Registry
Key facts
- Where
- Paris, FranceSee the site
Where in France
- Service des Urgences Cérébro-Vasculaires, Hôpitaux Universitaires Pitié-Salpêtrière et Saint-AntoineParis, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Trial code
- NCT05534360
- Record updated
- 9 September 2022
- Original description
The Tenecteplase Treatment in Acute Ischemic Stroke (TETRIS) Registry is multicenter ambispective observational study of patients with acute ischemic stroke who received intravenous thrombolysis with TenecteplaseRead full original descriptionShow less
Tenecteplase Treatment in Ischemic Stroke Registry
The Tenecteplase Treatment in Acute Ischemic Stroke (TETRIS) Registry is multicenter ambispective observational study of patients with acute ischemic stroke who received intravenous thrombolysis with Tenecteplase
Inclusion: Age 18 and older; Confirmed acute arterial ischemic stroke on brain imaging (CT or MRI) within 270 minutes of symptoms onset or with perfusion CT or MRI criteria for an extended treatment window or wake-up strokes; Intravenous thrombolysis with tenecteplase.
Exclusion: Venous ischemic stroke; Contra-indication to intravenous thrombolysis; Intravenous thrombolysis with alteplase.